Show All
Media Videos
Presentations
Press Releases

Government grant to apply NanoCelle® to an RNA nasal vaccine

Medlab (ASX:MDC) receives Government grant to apply NanoCelle® to an RNA nasal vaccine in collaboration with University of NSW (UNSW) and Macquarie University (MQ) to fight COVID-19 future potential epidemics.


Friday 14th January 2022

Read more
Now this is scalable – a drug delivery platform rather than a drug itself

Now this is scalable – a drug delivery platform rather than a drug itself

Listen to ASX-listed Medlab Clinical CEO Dr Sean Hall talk to Matt Birney on the Bulls N’ Bears Report on Deb Knight show on 873 am. (2GB), about Medlab’s development of a potent drug delivery platform that can potentially piggyback any drug to where it needs to go.


Friday 12th November 2021

Read more

Medlab Clinical Ltd (ASX:MDC) sells its Australian nutraceutical business to PharmaCare

We are pleased to announce the sale of the Australian-only part of its nutraceutical business to PharmaCare


Wednesday 27th October 2021

Read more

Annual Message to Shareholders October 2021

Once Medlab Clinical’s listing on the ASX six years ago its experienced team of scientists have made extraordinary advances in the creation and manufacture of unique, world-leading products and valuable intellectual property.


Wednesday 13th October 2021

Read more

Edison Group – Executive interview with CEO, Dr Sean Hall

In this video, Dr Sean Hall, Medlab’s co-founder and CEO, introduces us to Medlab and its lead programmes and discusses what we can expect from this fast-growing company over the coming months.


Sunday 29th August 2021

Read more

Jefferies Healthcare Conference - 2021

Medlab outlines its growth strategy for US and global investors at the prestigious annual Jefferies Healthcare Conference.


Saturday 26th June 2021

Read more

Medlab Clinical talks upcoming Phase III NanaBis trial and NanoCelle partnering opportunities

Medlab Clinical Ltd's (ASX:MDC) Dr Sean Hall tells Proactive's Andrew Scott they're focused on achieving regulatory approval for its lead drug candidate NanaBis™.


Thursday 24th June 2021

Read more

Small Caps interview of CEO Sean Hall

Small Caps interview of CEO Sean Hall


Thursday 22nd April 2021

Read more
Scientists with virtual reality glasses - Medlab Clincial

Medlab mixes reality with Microsoft

Read the three featured stories from Microsoft about Medlab's adoption of mixed reality solutions including HoloLens 2 head-mounted devices with Dynamics 365


Wednesday 14th April 2021

Read more
woman in pain - Medlab Clinical

NanaBis demonstrates continued improvement in pain scores

The first cohort of Observational Study patients completing 12-month treatment with NanaBis™ demonstrated continued improvement in pain scores.


Monday 12th April 2021

Read more
Scientists in Lab - Medlab Clinical

Medlab to be granted European patent for NanoCelle® drug delivery platform

European Patent Office issues Notice of Intention to grant Medlab Clinical patent for NanoCelle® drug delivery platform


Wednesday 7th April 2021

Read more
Cheryl Maley - Medlab Clinical

Novartis’ Managing Director of Oncology (ANZ/NZ) joins Medlab Clinical board

Medlab Clinical appoints Novartis' Managing Director of Oncology for Australia and New Zealand as Non-Executive Director.


Tuesday 23rd March 2021

Read more